Karachi: GlaxoSmithKline Pakistan Limited has announced a significant leadership change in its financial department. The company's Board of Directors has appointed Mr. Muhammad Yousuf Vohra as the new Finance Director and Chief Financial Officer, effective October 15, 2026. This appointment was disclosed in a material information report dated September 3, 2026.

Mr. Vohra, who previously served as the Finance Controlling Director for the Middle East and Africa (MEA) HUB, brings a wealth of experience to his new role at GlaxoSmithKline Pakistan Limited. His expertise in financial management within the region is expected to contribute to the company's strategic objectives.

According to information available from the Pakistan Stock Exchange (PSX), GlaxoSmithKline Pakistan Limited operates within the pharmaceutical sector, a key area in the designated market category. The company's decision to appoint Mr. Vohra reflects its commitment to strengthening financial governance and oversight.

As the company navigates through evolving market conditions, Mr. Vohra's leadership will be pivotal in steering financial strategies and ensuring compliance with industry standards. This move is anticipated to align with GlaxoSmithKline's long-term vision for growth and sustainability within the industry.